Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFK2V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,506
Award facts
- Contract value 100% obligated
- $52,505.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $52,505.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen injections on January 7, 2026, with a completion date of January 8, 2026. This is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026), which serves as the primary vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that supplies a comprehensive range of medications, medical devices, and healthcare commodities to federal agencies including the Department of Defense and Department of Veterans Affairs. This delivery order for Zepbound, a GLP-1 receptor agonist used in diabetes and weight management treatment, demonstrates the contractor's ongoing role in fulfilling specialized pharmaceutical needs for military healthcare systems. The award reflects AmerisourceBergen's established capability to meet federal procurement requirements through competitive procurement processes and its position as a critical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FFK2V?
SPE2DR26FFK2V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FFK2V worth?
The government has obligated $52,506 on SPE2DR26FFK2V.
Is contract SPE2DR26FFK2V an order under another contract?
Yes. SPE2DR26FFK2V is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFK2V competed?
The extent of competition for SPE2DR26FFK2V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award